Connecting Families to Overcome Ovarian Cancer

NCT04927013CompletedNAINTERVENTIONAL

Summary

Key Facts

Lead Sponsor

Emory University

Enrollment

2331

Start Date

2021-07-24

Completion Date

2023-02-21

Study Type

INTERVENTIONAL

Official Title

Testing a Low Cost Population- and Theory-Based Outreach Intervention to Engage Ovarian Cancer Survivors and Their Close Relatives to Consider Genetic Services

Interventions

Message-based Outreach Intervention for SurvivorsStandard Outreach for SurvivorsMessage-based Outreach Intervention for Close RelativesStandard Outreach for Close Relatives

Conditions

Ovarian Cancer

Eligibility

Age Range

18 Years+

Sex

ALL

Inclusion Criteria for Survivors:

* in the Georgia Cancer Registry (GSR)
* diagnosed with ovarian, fallopian tube, or peritoneal cancers
* lived in Georgia at the time of diagnosis
* not deceased per the registry's records
* have a mailing address in GSR records

Inclusion Criteria for Close Relatives:

* 25 years or older
* able to access the internet
* a 1st or 2nd degree relative of the survivor
* able to read English
* non-incarcerated or institutionalized

Exclusion Criteria:

* none

Outcome Measures

Primary Outcomes

Number of Survivors Using Website Access Code

Survivor reach is assessed as the number of the eligible survivors identified and contacted by GCR who used their unique login to access the study website.

Time frame: Up to 19 months

Number of Survivors Consenting to Participate in the Study

Survivor reach is assessed as the number of the eligible survivors identified and contacted by GCR who used their unique login code to access the study website and consented to participate in the study while visiting the website.

Time frame: Up to 19 months

Number of Survivors Creating a Study Login

Survivor reach is assessed as the number of the eligible survivors identified and contacted by GCR who access the study website, consented to participate in the study, and created their own personal study login on the website.

Time frame: Up to 19 months

Number of Relatives of Survivors Using the Website Access Code

Close relative reach is assessed as the number of close relatives enumerated by survivors who used their unique login code to access the study website.

Time frame: Up to 19 months

Number of Relatives of Survivors Consenting to Participate in the Study

Close relative reach is assessed as the number of close relatives enumerated by survivors who accessed the website and consented to participate in the study while they were using the website.

Time frame: Up to 19 months

Number of Relatives of Survivors Creating a Login

Close relative reach is assessed as the number of close relatives enumerated by survivors who accessed the study website, gave consent to participate in the study, and created their own personal study login on the study website.

Time frame: Up to 19 months

Secondary Outcomes

Relative Contact Option Selected by Survivors

Cancer survivors in the Message-based Outreach Intervention arm who accessed the website were asked to enumerate close relatives and choose from a menu of options about how the survivor would prefer for their relatives to be contacted.

Time frame: Up to 19 months

Number of Survivors Requesting Telegenetic Counseling

The request rate of cancer genetic services is assessed as the number of cancer survivors who requested telegenetic counseling on the website.

Time frame: Up to 19 months

Number of Survivors Completing Telegenetic Counseling

Uptake of cancer genetic services is assessed as the number of survivors who completed telegenetic counseling.

Time frame: Up to 19 months

Number of Relatives Requesting Telegenetic Counseling

The request rate of cancer genetic services is assessed as the number of close relatives who requested telegenetic counseling on the website.

Time frame: Up to 19 months

Number of Relatives Completing Telegenetic Counseling

Uptake of cancer genetic services by relatives of survivors is assessed as the number of relatives enumerated who completed the Breast Cancer Genetics Referral Screening Tool (B-RST) screening and subsequently accessed genetic counseling.

Time frame: Up to 19 months

Time Visiting Website by Survivors

The duration of time (in minutes) that survivors in the Message-based Outreach Intervention (MBI) study arm spent on the website was examined.

Time frame: Up to 19 months

Time Visiting Website by Relatives

Among those in the intervention arm, the duration of time (in minutes) that relatives of survivors spend on the website was examined.

Time frame: Up to 19 months

Number of Return Visits to Website by Survivors

The number of return visits to the website by survivors in the MBI study arm was examined.

Time frame: Up to 19 months

Number of Return Visits to Website by Relatives

Among those in the intervention arm, the number of return visits to the website by relatives of survivors was examined.

Time frame: Up to 19 months

Number of Pages Viewed by Survivors

The number of website page viewed by survivors in the MBI study arm was examined.

Time frame: Up to 19 months

Number of Pages Viewed by Relatives

Among those in the intervention arm, the number of website pages viewed by relatives of survivors will be examined.

Time frame: Up to 19 months

Locations

Emory University, Atlanta, United States

Linked Papers

2025-05-06

Trust and Privacy Concerns Among Cancer Survivors Who Did Not Visit a Research Website Offering Free Genetic Counseling Services for Families: Survey Study

Background Digital health tools, such as websites, now proliferate to assist individuals in managing their health. With user input, we developed the Your Family Connects (YFC) website to promote access to genetic services for survivors of ovarian cancer and their relatives. Although we estimated that half or more would access the website, only 18% of invited survivors did so. We assessed the extent to which perceived relevance of the information provided, trust, and privacy concerns influenced decisions not to access the website. Objective We designed a theory-based cross-sectional survey to explore the following questions: (1) To what extent did nonresponders endorse privacy concerns? (2) Were privacy concerns associated with recall of receiving the website invitation, time since diagnosis, age, and race? (3) Could we identify profiles of nonresponders that would guide the development of future interventions to encourage engagement in health websites for families affected by inherited cancers? Methods A sample of survivors who were eligible to access the website yet did not respond to the study invitation was identified by linking study IDs to the Georgia Cancer Registry information. The survey was brief and contained 27 items, including recall of the invitation, interest in ovarian cancer information, benefits of using health websites, trust in health websites, and trust in university-based health research. We conducted factor analyses, regression analyses, ANOVA, correlation analyses, and logistic regression to address research questions. Results Of the 650 nonresponders to whom we sent the short survey, 368 (56.3%) responded and provided sufficient data for analysis. The mean response of 2.57 on the trust scale was significantly below the scale midpoint of 3 (t360=11.78, P<.001), suggesting that survivors who did not log on were on average distrustful of health websites. Belonging to a racial or ethnic minority group was associated with being more trusting and less skeptical about health websites. Just 196 (30.1%) nonresponders recalled the invitation to visit the website. Logistic regression analysis indicated that age was the only significant predictor of recall. Testing a model with age, racial or ethnic minority status, and the 6 privacy concerns correctly classified 58.8% of nonresponders, a rate of successful classification that was not appreciably better than a logistic regression analysis that included only age as a predictor. Conclusions The nonresponders in the present study—particularly the White nonresponders—were skeptical of website platforms regardless of whether they recalled receiving a website invitation or not. Social marketing approaches geared toward building trust in web platforms by building a relationship with an information consumer and in collaboration with trusted organizations warrant further investigation. Trial Registration ClinicalTrials.gov NCT04927013; https://clinicaltrials.gov/study/NCT04927013

Testing a Population-Based Outreach Intervention for Ovarian Cancer Survivors to Encourage their Close Relatives to Consider Genetic Counseling

Abstract Background: Most relatives of women with ovarian cancer are unaware of their increased risk for cancer and their eligibility for genetic counseling. State cancer registries offer a platform to communicate about inherited risk to this population. Methods: We conducted a two-arm randomized trial to test a theory-based communication intervention—Your Family Connects (YFC)—compared to the standard Georgia Cancer Registry (GCR) contact. A total of 1,938 eligible ovarian cancer survivors were randomly assigned to either the YFC arm (n = 969) or the Standard Care arm (n = 969). We assessed the number of ovarian cancer survivors and their close relatives who logged on to the study website by arm. Results: Survivor reach was significantly higher in the Standard Care arm than YFC (20.8% vs. 15.2%, respectively; P < 0.001). However, reach to relatives was limited to listed relatives in the YFC arm (n = 20, 13.2%), with little participation from those in the Standard Care arm (n = 1, 0.4%). Pooling across arms, minority race, longer time since diagnosis, and older age were all significantly associated with a decreased likelihood that the survivor accessed the website. Conclusions: The YFC intervention showed lower effectiveness for engaging survivors but was more effective than Standard Care in engaging at-risk relatives. Other factors (e.g., time since diagnosis) associated with lower reach must be considered in refining future outreach approaches. Impact: Partnering with a state cancer registry to foster family communication about inherited cancer risk is feasible but the possibility for broad population reach warrants further testing.